Although NKG2A blockade had no impact on MC-38 tumor growth nor mouse survival of KVK vaccinated mice (Supplementary Figure S3), it significantly decreased the total number of vaccine-induced neoantigens-specific CD8 T cells, suggesting that the impact of anti-NKG2A is not antigen or tumor model dependent (Supplementary Figure S4A,B). This evidence concerns the gene CD8A and neoplasm.